Your browser doesn't support javascript.
loading
Do Tobacco Companies Have an Incentive to Promote "Harm Reduction" Products?: The Role of Competition.
Levy, David T; Thirlway, Frances; Sweanor, David; Liber, Alex; Maria Sanchez-Romero, Luz; Meza, Rafael; Douglas, Clifford E; Michael Cummings, K.
Afiliación
  • Levy DT; Oncology Department, Lombardi Comprehensive Center, Georgetown University, Washington, DC, USA.
  • Thirlway F; Sociology Department, University of York, Heslington, York, UK.
  • Sweanor D; Centre for Health Law, Policy and Ethics, University of Ottawa, Ottawa, Ontario, Canada.
  • Liber A; Oncology Department, Lombardi Comprehensive Center, Georgetown University, Washington, DC, USA.
  • Maria Sanchez-Romero L; Oncology Department, Lombardi Comprehensive Center, Georgetown University, Washington, DC, USA.
  • Meza R; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Douglas CE; Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Michael Cummings K; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charlestown, SC, USA.
Nicotine Tob Res ; 25(12): 1810-1821, 2023 Nov 22.
Article en En | MEDLINE | ID: mdl-36692328
ABSTRACT

INTRODUCTION:

Some cigarette companies have started to talk about replacing cigarettes with less harmful alternatives, which might include nicotine vaping products (NVPs), heated tobacco products (HTPs), and oral nicotine delivery products. We consider market competition as a primary driver of whether cigarette companies follow through on their stated intentions. AIMS AND

METHODS:

We focus on the behavior of cigarette companies in the United States. We compare competition in the pre- and post-2012 time periods, analyze the impact of the growth in NVPs on smoking prevalence and cigarette company profits, and examine the potential future role of competition.

RESULTS:

Since 2006, consumers have broadened their use of non-combustible nicotine delivery products (NCNDPs) to include, inter alia, NVPs, HTPs, and oral nicotine pouches. U.S. cigarette companies have acquired major stakes in each of these product categories which corresponds to a period of rapidly declining adult smoking prevalence, especially among younger adults (ages 18-24 years). The shifting dynamics of the nicotine product marketplace are also reflected in cigarette company stock prices. While cigarette companies are likely to promote HTPs and nicotine delivery products over NVPs, their incentives will be directly related to competition from independent firms, which in turn will depend on government regulation.

CONCLUSIONS:

Although cigarette companies will back alternatives to combusted tobacco when threatened by competition, the prospects for their lasting conversion to NCNDPs will depend on the extent of such competition, which will be influenced by government regulation of tobacco products. IMPLICATIONS Regulations that limit competition from independent firms while also protecting cigarette company profits risk slowing or even reversing recent declines in smoking, especially among youth and young adults. Regulations that reduce the appeal and addictiveness of combusted tobacco products, such as higher cigarette taxes or a reduced nicotine standard, will encourage smokers to quit and/or switch to less harmful non-combusted forms of tobacco. The regulation of non-combustible nicotine delivery products and cigarettes should be proportionate to their relative risks, so that smokers have incentives to switch from combustibles to safer alternatives, and cigarette companies have incentives to promote safer products.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders Asunto principal: Productos de Tabaco / Sistemas Electrónicos de Liberación de Nicotina / Vapeo Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Nicotine Tob Res Asunto de la revista: SAUDE PUBLICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders Asunto principal: Productos de Tabaco / Sistemas Electrónicos de Liberación de Nicotina / Vapeo Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Nicotine Tob Res Asunto de la revista: SAUDE PUBLICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...